Skip to main content

January 2023 Vol 16, No 1

Shortened Radiation Schedule Safe and Effective in Men with High-Risk Prostate Cancer
By Patricia Stewart
ASTRO Highlights
January 2023 Vol 16, No 1
A shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer, according to the results of the phase 3 Prostate Cancer Study 5 (PCS5) trial.
Read More ›
FDA News: October 21, 2022, and December 1, 2022
FDA News & Updates
January 2023 Vol 16, No 1
This section provides a brief overview of new cancer drugs and new indications approved by the FDA between October 21, 2022, and December 1, 2022.
Read More ›

Page 2 of 2